UK Studies: Opioid Overdose Deaths Increase Among Black Individuals
LEXINGTON, Ky. (Oct. 6, 2021) — Recent studies by the University of Kentucky's HEALing Communities Study (Helping to End Addiction Long-term) researchers show a notable rise in opioid overdose death rates among non-Hispanic Black individuals.
Opioid overdose death rates increased by 40% among non-Hispanic Black individuals between 2018 and 2019, despite having leveled off overall, according to study results published in the American Journal of Public Health this September.
The death rate trends were determined using data from 67 communities disproportionately affected by opioid overdose, which represent 8.3 million individuals in Kentucky, Massachusetts, New York and Ohio.
Another UK study published in JAMA this July found that the increase in opioid overdose death rates among Black individuals continued over the next year, rising 57% in Kentucky from 2019-2020.
Historically, opioid overdose death rates have been disproportionately higher among white individuals. The new shifting demographics are shaping the way UK’s HEALing Communities Study (HCS) research team is helping to address the opioid epidemic in Kentucky, says Sharon Walsh, Ph.D., the principal investigator for UK's HCS and director of UK’s Center on Drug and Alcohol Research.
“The data are being used to help inform communities about evidence-based practices proven to reduce opioid overdose,” said Walsh. “The HCS team is developing and implementing more culturally tailored interventions to reach communities of color in Kentucky, which face additional barriers to accessing treatment.”
This includes outreach events in Black communities, which include overdose education and distribution of naloxone — a life-saving, highly effective medication that rapidly reverses an opioid overdose.
The JAMA study also reports a significant increase in drug overdose mortality across all demographic groups in Kentucky in 2020 when the COVID-19 pandemic began. The UK study was released before the CDC released their provisional 2020 estimates.
“Kentucky has one of the most timely drug overdose surveillance data collection and reporting in the U.S. and the UK research team has been on the front line, informing other practitioners and researchers about changing trends in non-fatal and fatal drug overdoses,” said study co-author Svetla Slavova, Ph.D., associate professor in the UK College of Public Health’s Department of Biostatistics and faculty member in the Kentucky Injury Prevention and Research Center.
Funded by the National Institutes for Health (NIH) and the Substance Abuse and Mental Health Services Administration (SAMHSA), the HCS aims to significantly reduce opioid overdose deaths by helping communities implement evidence-based practices to treat opioid use disorder and reduce harms from opioid use. Learn more at www.uky.edu/healingstudy/.
Research reported in this publication was supported by funding from the Centers for Disease Control and Prevention under Award Number 6 NU17CE924971-02-01, by the U.S. Food and Drug Administration under Award Number HHSF223201810183C under Broad Agency Announcement Number 17-00123, and by the National Institutes of Health through the Helping to End Addiction Long-term Initiative under Award Numbers UM1DA049406, UM1DA049412, UM1DA049415, UM1DA049417 and UM1DA049394. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control and Prevention, U.S. Food and Drug Administration or the National Institutes of Health.
As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.
In 2022, UK was ranked by Forbes as one of the “Best Employers for New Grads” and named a “Diversity Champion” by INSIGHT into Diversity, a testament to our commitment to advance Kentucky and create a community of belonging for everyone. While our mission looks different in many ways than it did in 1865, the vision of service to our Commonwealth and the world remains the same. We are the University for Kentucky.